Detolio, Susana R.
HRN: 22-40-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/28/2022
01/04/2023
IV DRIP
500mg
Q8H
AGE Severe Probably 2° To Intestinal Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes